FDAnews Device Daily Bulletin

ALLERGAN: FORECASTING SALES GROWTH

March 30, 2006
A A

In addition to promoting Allergan into a leading position within the market for breast implants, the acquisition of Inamed has also given Allergan a key role in the field of anti-obesity devices. Inamed's Lap-Band gastric band is currently the sole FDA-approved device on the US market to treat obesity.

Black Enterprise (http://www.blackenterprise.com/yb/ybopen.asp?section=ybbf&story_id=91169124&ID=blackenterprise)